http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2108581-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c172daf2461a74d9880e16d50998795
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0428134a460fc384043fcc1b5c75db21
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-00
filingDate 1995-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51eefedaeedc7bb8454a720dd6d5bb76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aae28f9de09ee8b400295f6af3174126
publicationDate 1998-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2108581-C1
titleOfInvention Method for determining human magnetic sensitivity degree
abstract FIELD: medicine. SUBSTANCE: method involves studying one of liquid media in organism, like blood serum that is to be mixed with Liesegang solution. Serum rings formation time is measured before and after acting with magnetic field. The time after action applied being shortened to 30% when compared to the initial one, sensitivity is considered to be feeble. When the value is between 31 and 50%, sensitivity is considered to be moderate. The value being greater than 50%, sensitivity is considered to be high. EFFECT: enhanced effectiveness of method. 1 tbl
priorityDate 1995-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450313723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451637024
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53471866

Total number of triples: 19.